Interpace Biosciences (IDXG) Reports Q2 EPS of $0.48

Interpace Biosciences (OTC: IDXG) reported Q2 EPS of $0.48, Revenue for the quarter came in at $12 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• TNL Mediagene faces Nasdaq delisting over bid price and equity rules
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story